Winer Gary M's Form 4 filing
HCW Biologics Inc. (HCWB) · filed Sep 7, 2023
- Accession no.
- 0001209191-23-048652
- Filed
- Sep 7, 2023
- Trade date
- Sep 5-7, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $822.85. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Winer Gary MCIK 0001822095 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 5, 2023 | Common Stock | PPurchaseAcquired | +400 | $1.75 | +$700 | 14,750 | Direct | |
| Sep 7, 2023 | Common Stock | PPurchaseAcquired | +63 | $1.95 | +$122.85 | 14,813 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.